[ad_1]
12:46 PM
Thursday May 14, 2020
I wrote – Rana Osama:
As the world continues its war against the emerging Corona pandemic, United States President Donald Trump appointed Moroccan researcher Monsef Mohamed Salawi as senior adviser to lead efforts by the United States government to develop an effective vaccine against the virus that continues to harvest tens of thousands of people since it started its progressive journey from the Chinese city of Wuhan 5 months ago.
According to Reuters, it was decided to appoint Al-Salawi, the former head of the “GlaxoSmithKline” vaccine division, to accelerate the development of the new coronavirus vaccine by the United States as part of a committee called “Operation Warp Speed “
The Moroccan doctor and researcher will work with US Surgeon General Gustave Berna, and will oversee that committee’s efforts to develop, test, and produce the vaccine in a short period of time to combat the pandemic.
According to Moroccan media reports, Al-Salawi, 61, worked for the research and development division of GlaxoSmithKline between 2015 and 2017, and helped develop vaccines to prevent malaria, stomach and intestinal infections in children and the cervical cancer.
He is also a member of the board of directors of the “Moderna” company that conducted the first vaccine test for a woman in Corona, and a member of Hamad Bin Khalifa University in Qatar, and previously worked with a group of epidemiology professors to find vaccines. related to HIV. “
He left Morocco at age 17 to study medicine in France, then traveled to Belgium, where he settled for 27 years, during which he studied molecular biology and received a doctorate in immunology from the Free University of Brussels.
He completed postdoctoral studies at Harvard Medical School and Tufts University School of Medicine in Boston, according to his CV posted on the Hamad Bin Khalifa University website.
Author of more than 100 books and scientific presentations, he is a member of the Board of Directors of the PhRMA Foundation and the Board of Directors of the American Organization of the Biotechnology Industry.
Al-Salawi, a specialist in immunology and virology in the United States of America, confirmed that 800 clinical studies are being conducted worldwide to identify all the characteristics related to the emerging virus that causes the “Covid 19” disease and work to surround it.
He explained in a previous meeting with the program “Talk with the Press” on the second Moroccan channel, that among the obstacles that the world will face after finding a Corona vaccine is the possibility of saving billions, which requires a lot of time, efforts and capabilities before it reaches people around the world. According to the Moroccan website “Hespress”.
